Clinical Trial

Impact of Perioperative Dexmedetomidine and Esketamine on Postoperative Quality of Recovery

Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
For patients after surgery, quality of recovery has significant impacts on the prognosis, quality of life, and rational allocation of medical resources. Dexmedetomidine and esketamine have each been used during the perioperative period and improved postoperative analgesia and subjective sleep quality. This 2x2 factorial trial is designed to explore the effects of dexmedetomidine, esketamine, and their combination on the quality of recovery in patients recovering from surgery under general anesthesia.
Protocol Amendment History 3 changes
critical Recruitment opened 2026-04-14
notable Primary completion pushed: 2026-03 -> 2027-03 2026-04-14
minor Completion pushed: 2026-04 -> 2027-04 2026-04-14
Trial Details
NCT Number NCT07308756
Lead Sponsor Peking University First Hospital
Conditions General Anesthesia, Surgery, Dexmedetomidine, Esketamine, Quality of Recovery
Enrollment 316 participants
Start Date 2026-01-05
Primary Completion 2027-03 (estimated)
Study Completion 2027-04 (estimated)
Updated on ClinicalTrials.gov 2026-04-13